Showing results (1921-1930 of 1,933) with videos related to
Sort By:
Pageof 194
Cellular and Molecular Gastroenterology and Hepatology|September 15, 2020
Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy ResistanceJiaye Liu, Pengfei Li, Ling Wang, et al.Nature|March 22, 2022
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19Lok-Yin Roy Wong, Jian Zheng, Kevin Wilhelmsen, et al.Nature|October 30, 2025
Multiple LDLR family members act as entry receptors for yellow fever virusZhenlu Chong, Sean Hui, Xueer Qiu, et al.Nature Communications|May 14, 2025
Macrophage-augmented intestinal organoids model virus-host interactions in enteric viral diseases and facilitate therapeutic developmentGuige Xu, Jiangrong Zhou, Kuan Liu, et al.Science Translational Medicine|April 19, 2019
Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1Shiming Peng, Wen Xiao, Dapeng Ju, et al.Nature Communications|July 2, 2025
Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trialNan Niu, Jinqi Xue, Guanglei Chen, et al.Nature|November 12, 2025
iPEX enables micrometre-resolution deep spatial proteomics via tissue expansionFengxiang Wang, Cuiji Sun, Tianshu William Wu, et al.Nature Communications|November 17, 2022
A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancerNan Niu, Fang Qiu, Qianshi Xu, et al.Cellular and Molecular Life Sciences : CMLS|January 22, 2025
Synergistic combination of orally available safe-in-man pleconaril, AG7404, and mindeudesivir inhibits enterovirus infections in human cell and organoid culturesErlend Ravlo, Aleksandr Ianevski, Jørn-Ove Schjølberg, et al.Nature Biomedical Engineering|June 13, 2025
Macrophage-augmented organoids recapitulate the complex pathophysiology of viral diseases and enable development of multitarget therapeuticsKuan Liu, Yining Wang, Jiajing Li, et al.Pageof 194